Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Understanding what not to do when budgeting is crucial for financial success. Learn the common mistakes to steer clear of.
26,044 articlesAxsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
IonQ stands out in the quantum race thanks to its accuracy edge. This article breaks down why ionq: quantum computing...
AMD has surged dramatically, but the AI data-center boom could still offer upside. This guide explores whether late a...
Arm Holdings stunned markets with a powerful run, then pulled back after earnings. This guide breaks down whether thi...
Plug Power's Q1 2026 earnings call offers a window into a fast-evolving hydrogen economy. This guide breaks down reve...
The United States and Europe are pursuing different routes to regulate AI, and the early market impact is clear—from ...
Canadian travel to the United States is declining beyond leisure trips, with business travel and investor visits fall...
Bank of America lifts Micron Technology's price target to $950, arguing a larger AI data-center market drives sustain...
A leading voice in personal finance questions the premise of hitting a $1 million target by age 25, urging young adul...
A longtime i’m berkshire hathaway investor shifts view on Greg Abel, arguing his disciplined capital allocation and r...
Tesla sits around $445 as Q1 margin gains meet AI roadmap momentum, prompting fresh Buy, Sell or Hold questions for i...
A growing number of high earners are tapping in-service distributions from 401(k) plans to avoid RMDs, turning the $1...